Back to top

Akorn (AKRX) in Focus: Stock Moves 5.0% Higher
February 25, 2014

Read MoreHide Full Article
Akorn, Inc. (AKRX - Free Report) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 28% since Feb 5.

This drug manufacturer has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Akorn currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Mallinckrodt plc (MNK - Free Report) , Actavis plc and Dr. Reddy's Laboratories Ltd. (RDY - Free Report) . While Mallinckrodt holds a Zacks Rank #1 (Strong Buy), Actavis and Dr. Reddy's Laboratories carry a Zacks Rank #2 (Buy

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Akorn, Inc. (AKRX) - free report >>

Mallinckrodt PLC (MNK) - free report >>

Dr. Reddy's Laboratories Ltd (RDY) - free report >>


More from Zacks Tale of the Tape

You May Like